Veradermics Finishes Phase 3 Trial Enrollment For VDPHL01
09 Feb 2026 //
BUSINESSWIRE
Veradermics Locks In $256M IPO, Shares Spike
05 Feb 2026 //
FIERCE PHARMA
Eikon, Veradermics Announce IPO Targets Amid Cautious Optimism
29 Jan 2026 //
BIOSPACE
Veradermics, Eikon Eye Public Market Debut As IPO Tap Opens
12 Jan 2026 //
BIOSPACE
Veradermics Advances VDPHL01 Trial For Male Pattern Hair Loss
11 Dec 2025 //
BUSINESSWIRE
Veradermics VDPHL01 Enters Phase 2/3 for Female Pattern Hair Loss
18 Nov 2025 //
BUSINESSWIRE
Veradermics Secures $150M For VDPHL01 Phase 3 Trials In Hair
16 Oct 2025 //
BUSINESS WIRE

Market Place
Sourcing Support